Article Details
Retrieved on: 2024-03-05 21:50:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company will present pre-clinical data describing the activity of HMBD-001, a clinical-stage anti-HER3 monoclonal antibody (mAb) currently in ...
Article found on: www.prnewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here